VRCA Verrica Pharmaceuticals Inc.
$2.88
Verrica Pharmaceuticals Inc. (VRCA) Earnings News
Earnings press releases, previews and reviews for Verrica Pharmaceuticals Inc. (VRCA), newest first. Our most recent is review: Verrica Misses on EPS as Record YCANTH Sales Rest on Pricing Yield, Not Volume, and the Cash Runway Shrinks.
Thursday
November 12, 2026
6:57 PM ET
Verrica Misses on EPS as Record YCANTH Sales Rest on Pricing Yield, Not Volume, and the Cash Runway Shrinks
Earnings Whispers · Review
Thursday
November 12, 2026
4:16 PM ET
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
Thursday
November 5, 2026
12:16 PM ET
Verrica Must Prove YCANTH Momentum Survived Summer as Shares Slide Toward Lows
Earnings Whispers · Preview
Thursday
November 5, 2026
8:00 AM ET
Verrica Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
Thursday
August 6, 2026
4:05 PM ET
Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
Thursday
July 30, 2026
8:00 AM ET
Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026